Women and Cancer
When it comes to women’s health, molecular diagnostics are playing a bigger role than ever before in uncovering how sex differences are expressed in cancer.
Read MorePosted by Jenny Lower | Jul 30, 2014 | Cancer, Heart Disease, Osteoporosis, Womens Health |
When it comes to women’s health, molecular diagnostics are playing a bigger role than ever before in uncovering how sex differences are expressed in cancer.
Read MorePosted by Jenny Lower | May 27, 2014 | Cancer, Prostate |
The National Comprehensive Cancer Network has recommended the Beckman Coulter Prostate Health Index (PHI) as a blood test that can improve specificity for prostate cancer detection and reduce the need for unnecessary biopsies.
Read MorePosted by Jenny Lower | Dec 16, 2013 | Breast, Cancer, Molecular Diagnostics, Research |
In a recent clinical study, a hereditary cancer test from Myriad Genetics detected breast and ovarian cancer 51% more often than tests for BCRA1 or BCRA2 genes alone.
Read MorePosted by Judy O'Rourke | Oct 29, 2013 | Cancer, Lung Cancer, Molecular Diagnostics |
Test accurately identifies which patients may need postsurgical chemotherapy.
Read MorePosted by Judy O'Rourke | Oct 15, 2013 | Breast, Cancer, Molecular Diagnostics, Unknown Origin & Other Cancer Types |
Quest also releases results from a national Harris survey revealing widespread confusion about BRCA testing.
Read More